Yeah mate. Options are looking strong. Glad I bought in the first week. Woo hoo. Such little risk for the potential reward IMO. Holding on to mine like a dog to his bone.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%